Ronald J Prentki - Net Worth and Insider Trading
Ronald J Prentki Net Worth
The estimated net worth of Ronald J Prentki is at least $137,670 dollars as of 2024-11-13. Ronald J Prentki is the President of Progenics Pharmaceuticals Inc and owns about 33,578 shares of Progenics Pharmaceuticals Inc (PGNX) stock worth over $137,670. Details can be seen in Ronald J Prentki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ronald J Prentki has not made any transactions after 2005-02-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ronald J Prentki
Ronald J Prentki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ronald J Prentki owns 2 companies in total, including Heron Therapeutics Inc (HRTX) , and Progenics Pharmaceuticals Inc (PGNX) .
Click here to see the complete history of Ronald J Prentki’s form 4 insider trades.
Insider Ownership Summary of Ronald J Prentki
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2009-07-08 | director & President & CEO |
| PGNX | Progenics Pharmaceuticals Inc | 2005-02-07 | director & President |
Ronald J Prentki Latest Holdings Summary
Ronald J Prentki currently owns a total of 1 stock. Ronald J Prentki owns 33,578 shares of Progenics Pharmaceuticals Inc (PGNX) as of February 7, 2005, with a value of $137,670.
Latest Holdings of Ronald J Prentki
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PGNX | Progenics Pharmaceuticals Inc | 2005-02-07 | 33,578 | 4.10 | 137,670 |
Holding Weightings of Ronald J Prentki
Ronald J Prentki Form 4 Trading Tracker
According to the SEC Form 4 filings, Ronald J Prentki has made a total of 0 transactions in Progenics Pharmaceuticals Inc (PGNX) over the past 5 years. The most-recent trade in Progenics Pharmaceuticals Inc is the sale of 26,000 shares on February 7, 2005, which brought Ronald J Prentki around $548,340.
Insider Trading History of Ronald J Prentki
- 1
Ronald J Prentki Trading Performance
Ronald J Prentki Ownership Network
Ownership Network List of Ronald J Prentki
Ownership Network Relation of Ronald J Prentki
Ronald J Prentki Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
Ronald J Prentki is the director & President & CEO of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc (HRTX) Insider Trades Summary
Over the past 18 months, Ronald J Prentki made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
Ronald J Prentki Mailing Address
Above is the net worth, insider trading, and ownership report for Ronald J Prentki. You might contact Ronald J Prentki via mailing address: 4 Charter Oak Lane, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
